Biblio
Export 72 results:
Author Title [ Type] Year Filters: First Letter Of Title is G [Clear All Filters]
“Gypenoside XVII Enhances Lysosome Biogenesis and Autophagy Flux and Accelerates Autophagic Clearance of Amyloid-β through TFEB Activation.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1135-50, 2016.
, “Gx-50 Inhibits Neuroinflammation via α7 nAChR Activation of the JAK2/STAT3 and PI3K/AKT Pathways.”, J Alzheimers Dis, vol. 50, no. 3, pp. 859-71, 2016.
, “The GWAS Risk Genes for Depression May Be Actively Involved in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1149-1161, 2018.
, “Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer's Disease.”, J Alzheimers Dis, vol. 81, no. 2, pp. 583-595, 2021.
, “The Gut Microbiota and Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 1-15, 2017.
, “Gut Microbiota Alterations and Cognitive Impairment Are Sexually Dissociated in a Transgenic Mice Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. s1, pp. S195-S214, 2021.
, “Gut Microbiota Alteration and Its Time Course in a Tauopathy Mouse Model.”, J Alzheimers Dis, vol. 70, no. 2, pp. 399-412, 2019.
, “Gut Microbiome is Altered in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1337-1346, 2018.
, “Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 80, no. 1, pp. 299-310, 2021.
, “The GSM BPN-15606 as a Potential Candidate for Preventative Therapy in Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1541-1554, 2020.
, “GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner.”, J Alzheimers Dis, vol. 49, no. 2, pp. 365-75, 2016.
, “Growth Hormone-Releasing Hormone Modulation of Neuronal Exosome Biomarkers in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 66, no. 3, pp. 971-981, 2018.
, “Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 59-65, 2017.
, “Greater than the Sum of Its Parts: δ can be Constructed from Item Level Data.”, J Alzheimers Dis, vol. 49, no. 2, pp. 571-9, 2016.
, “Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 93-100, 2016.
, “Greater Regional Cortical Thickness is Associated with Selective Vulnerability to Atrophy in Alzheimer's Disease, Independent of Amyloid Load and APOE Genotype.”, J Alzheimers Dis, vol. 69, no. 1, pp. 145-156, 2019.
, “Gradual Cerebral Hypoperfusion Impairs Fear Conditioning and Object Recognition Learning and Memory in Mice: Potential Roles of Neurodegeneration and Cholinergic Dysfunction.”, J Alzheimers Dis, vol. 61, no. 1, pp. 283-293, 2018.
, “Google Calendar Enhances Prospective Memory in Alzheimer's Disease: A Case Report.”, J Alzheimers Dis, vol. 57, no. 1, pp. 285-291, 2017.
, “Glutathione Conformations and Its Implications for in vivo Magnetic Resonance Spectroscopy.”, J Alzheimers Dis, vol. 59, no. 2, pp. 537-541, 2017.
, “Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 145-59, 2016.
, “Glucose Transporters in Brain: In Health and in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1307-1320, 2017.
, “Glucose Fluctuations Are Linked to Disrupted Brain Functional Architecture and Cognitive Impairment.”, J Alzheimers Dis, vol. 74, no. 2, 2020.
, “Glucometabolic Changes Are Associated with Structural Gray Matter Alterations in Prodromal Dementia.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1293-1302, 2022.
, “Glucagon-Like Peptide-2 Receptor is Involved in Spatial Cognitive Dysfunction in Rats After Chronic Cerebral Hypoperfusion.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1559-1576, 2018.
, ,